BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 22860153)

  • 1. Significantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatment.
    Landouré A; Dembélé R; Goita S; Kané M; Tuinsma M; Sacko M; Toubali E; French MD; Keita AD; Fenwick A; Traoré MS; Zhang Y
    PLoS Negl Trop Dis; 2012; 6(7):e1774. PubMed ID: 22860153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of persistent hotspots of Schistosoma mansoni in western Côte d'Ivoire.
    Assaré RK; N'Tamon RN; Bellai LG; Koffi JA; Mathieu TI; Ouattara M; Hürlimann E; Coulibaly JT; Diabaté S; N'Goran EK; Utzinger J
    Parasit Vectors; 2020 Jul; 13(1):337. PubMed ID: 32616074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors of schistosomiasis among primary school children in four selected regions of The Gambia.
    Joof E; Sanyang AM; Camara Y; Sey AP; Baldeh I; Jah SL; Ceesay SJ; Sambou SM; Sanyang S; Wade CM; Sanneh B
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009380. PubMed ID: 33974623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
    Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
    PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-assessment of schistosomiasis in nine endemic districts with cluster sampling in Sierra Leone.
    Kargbo-Labour I; Redwood-Sawyerr V; Conteh A; Chop E; Bah MS; Koroma A; Kabia U; Klein L; Juneja S; Houck P; Reid S; Evans D; Weaver AM; Phillips AE; Zhang Y
    Front Public Health; 2024; 12():1415486. PubMed ID: 38932788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosoma haematobium hotspots in south Nyanza, western Kenya: prevalence, distribution and co-endemicity with Schistosoma mansoni and soil-transmitted helminths.
    Sang HC; Muchiri G; Ombok M; Odiere MR; Mwinzi PN
    Parasit Vectors; 2014 Mar; 7():125. PubMed ID: 24667030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-geographical heterogeneity in Schistosoma mansoni and S. haematobium infection and morbidity in a co-endemic community in northern Senegal.
    Meurs L; Mbow M; Boon N; van den Broeck F; Vereecken K; Dièye TN; Abatih E; Huyse T; Mboup S; Polman K
    PLoS Negl Trop Dis; 2013; 7(12):e2608. PubMed ID: 24386499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
    Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP
    Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.
    Shen Y; King CH; Binder S; Zhang F; Whalen CC; Evan Secor W; Montgomery SP; Mwinzi PNM; Olsen A; Magnussen P; Kinung'hi S; Phillips AE; Nalá R; Ferro J; Aurelio HO; Fleming F; Garba A; Hamidou A; Fenwick A; Campbell CH; Colley DG
    BMC Infect Dis; 2017 Sep; 17(1):652. PubMed ID: 28962552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between infection intensity categories and morbidity prevalence in school-age children are much stronger for Schistosoma haematobium than for S. mansoni.
    Wiegand RE; Secor WE; Fleming FM; French MD; King CH; Deol AK; Montgomery SP; Evans D; Utzinger J; Vounatsou P; de Vlas SJ
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009444. PubMed ID: 34033646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human schistosomiasis in Benin: Countrywide evidence of Schistosoma haematobium predominance.
    Onzo-Aboki A; Ibikounlé M; Boko PM; Savassi BS; Doritchamou J; Siko EJ; Daré A; Batcho W; Massougbodji A; Tougoue JJ; Kaboré A
    Acta Trop; 2019 Mar; 191():185-197. PubMed ID: 30633895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of mixed Schistosoma mansoni and Schistosoma haematobium infections in northern Senegal.
    Meurs L; Mbow M; Vereecken K; Menten J; Mboup S; Polman K
    Int J Parasitol; 2012; 42(3):305-11. PubMed ID: 22366733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosomiasis - Assessing Progress toward the 2020 and 2025 Global Goals.
    Deol AK; Fleming FM; Calvo-Urbano B; Walker M; Bucumi V; Gnandou I; Tukahebwa EM; Jemu S; Mwingira UJ; Alkohlani A; Traoré M; Ruberanziza E; Touré S; Basáñez MG; French MD; Webster JP
    N Engl J Med; 2019 Dec; 381(26):2519-2528. PubMed ID: 31881138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
    Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder morbidity and hepatic fibrosis in mixed Schistosoma haematobium and S. mansoni Infections: a population-wide study in Northern Senegal.
    Meurs L; Mbow M; Vereecken K; Menten J; Mboup S; Polman K
    PLoS Negl Trop Dis; 2012; 6(9):e1829. PubMed ID: 23029589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PREVALENCE AND INTENSITY OF SINGLE AND MIXED SCHISTOSOMA MANSONI AND SCHISTOSOMA HAEMATOBIUM INFECTIONS IN PRIMARY SCHOOL CHILDREN IN RACHUONYO NORTH DISTRICT, HOMABAY COUNTY, WESTERN KENYA.
    Amollo DA; Kihara JH; Kombe Y; Karanja SM
    East Afr Med J; 2013 Feb; 90(2):36-44. PubMed ID: 26866100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schistosomiasis in infants and preschool-aged children: Infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger.
    Garba A; Barkiré N; Djibo A; Lamine MS; Sofo B; Gouvras AN; Bosqué-Oliva E; Webster JP; Stothard JR; Utzinger J; Fenwick A
    Acta Trop; 2010 Sep; 115(3):212-9. PubMed ID: 20303925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.